Clinical Science Research and Development Service Cooperative Studies Scientific Merit Review Board; Notice of Meeting, 27635-27636 [07-2395]
Download as PDF
Federal Register / Vol. 72, No. 94 / Wednesday, May 16, 2007 / Notices
www.cbp.gov) as proof of designation of
the Account Owner. This document
must be signed by both the Account and
the Account Owner and submitted to
the Account Administrator. In cases in
which the Account Owner is an entity,
the form must be signed by the single
point of contact of the Account.
B. Account Owner
1. The Account Owner, as the
representative of the Account with
respect to all information submitted by
or on behalf of the Account, is
responsible for safeguarding Account
information, authorizing user access to
the ACE Portal account information,
controlling all disclosures of that
information, enforcing ACE Portal
access limitations, and ensuring the
strict control of access by authorized
persons to the ACE Portal information.
2. The Account Owner assumes
liability for any disclosure of Account
information or unauthorized access to
the ACE Portal and holds CBP, its
officers, agents, and employees harmless
from the release of any such
information.
3. The Account Owner administers
and controls all Proxy Account Owners
and Account User access, including the
designation and limitation of access, to
the ACE Portal. The Account Owner is
authorized to grant full or limited access
to information relating to the Account
(including information protected by the
Trade Secrets Act or Privacy Act),
through the ACE Portal.
4. The Account Owner, if not an
individual, shall designate an
individual as the single point of contact
for the Account relating to the
administration of access to the
Account’s information through the ACE
Portal.
C. All Parties
The Account Owner, Proxy Account
Owner, and any Account Users are
responsible for ensuring the accuracy
and confidentiality of any information
they submit through the ACE Portal to
CBP, and are also responsible for
complying with the record-keeping
requirements in accordance with law
including, but not limited to, 19 U.S.C.
1508 and 1509.
cprice-sewell on PROD1PC66 with NOTICES
V. Failure To Access the Portal
The failure of an Account Owner to
access the ACE Portal for a period of
ninety (90) days, consecutively, will
result in the termination of access to the
ACE Portal. Access may be restored by
calling the Help Desk or by following
the ‘‘forgot your password’’ prompt
found on the ACE Portal log-in page.
VerDate Aug<31>2005
15:27 May 15, 2007
Jkt 211001
The failure of a Proxy Account Owner
or an Account User to access the ACE
Portal for a period of ninety (90) days,
consecutively, will result in the
termination of access to the ACE Portal
for the Proxy Account Owner or
Account User. Access may only be
restored upon re-authorization by the
Account Owner.
VI. Change in the Status of the Account
or Account Owner
A. Change in the Status of the Account
1. The Account must provide notice
to CBP as soon as practicable, relating
to a material change to the status or
condition of the Account, such as a
transfer of IR number(s), SCAC(s), or
filer codes(s). Any transfer of control of
an IR number, SCAC or filer code, will
require notification to the CBP assigned
Account Manager or the ACE Portal
Administrator by the acquiring and
acquired parties. Until such notification,
CBP will not alter access to the Portal.
Some material changes will also require
re-application. For example, any
reorganization of an Account resulting
in the creation of a new company and
a new IR number, SCAC or filer code,
will require re-application; this does not
include the addition of a subsidiary. In
the event of a division or spin-off from
an Account, the Account will retain
access to the ACE Portal, and the new
business entity formed from the division
or spin-off must apply for access.
2. In the event of a material change in
the status of the Account, such as the
transfer of IR number(s), SCAC(s), or
filer codes(s), CBP will require a brief
summary of the change, signed by both
the acquiring and acquired parties,
including, but not limited to, the
following information:
a. Company names;
b. IR numbers acquired, transferred,
sold, or divested;
c. Party transferring the IR number,
filer code, and/or SCAC;
d. Party acquiring the IR number, filer
code, and/or SCAC;
e. Address changes; and
f. Effective date of information
control.
3. When the CBP assigned Account
Manager or ACE Portal Administrator is
notified of the transfer of IR number(s),
SCAC(s) or filer code(s), ACE Portal
access will be denied for the acquired
company unless the acquiring company
authorizes access to the acquired
company.
B. Change in the Status of the Account
Owner
1. The Account must provide notice
to CBP, as soon as practicable, relating
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
27635
to a material change in the status of the
Account Owner. A material change
includes the resignation of the Account
Owner. The Account must designate a
new Account Owner to act on behalf of
the Account after notifying CBP of the
change. At such time that a new
Account Owner is designated for the
Account, the Account must submit a
new Account Owner Designation/
Authorization form to the CBP assigned
Account Manager or Portal
Administrator.
2. If the Account Owner is not an
individual, the Account Owner must
provide notice to CBP, as soon as
practicable, relating to a material change
to the status of the single point of
contact. At such time that a new single
point of contact is designated for the
Account Owner, the Account Owner
must submit a new Account Owner
Designation/Authorization form to the
CBP assigned Account Manager or
Portal Administrator.
VII. Access to Historical Information
In the event of a transfer of control of
an IR number, filer code, and/or SCAC,
the acquiring company will obtain
access to historical information
associated with that IR number, filer
code, and/or SCAC. In the event that the
acquired company also requires access
to the historical information associated
with the transfer of control of an IR
number, filer code, and/or SCAC, the
acquired company’s access to that
information may be obtained by either
downloading the historical information
prior to the date of sale or the transfer
of control of an IR number, filer code,
and/or SCAC, or by making a Freedom
of Information Act (FOIA) request to
CBP of a download of that information
after the sale or the transfer of control
of an IR number, filer code, and/or
SCAC. In the alternative, the acquired
company may request to be made a user
on the acquiring company’s Account.
Dated: May 9, 2007.
Jayson P. Ahern,
Assistant Commissioner, Office of Field
Operations.
[FR Doc. E7–9350 Filed 5–15–07; 8:45 am]
BILLING CODE 9111–14–P
DEPARTMENT OF VETERANS
AFFAIRS
Clinical Science Research and
Development Service Cooperative
Studies Scientific Merit Review Board;
Notice of Meeting
The Department of Veterans Affairs
(VA) gives notice under Public Law 92–
463 (Federal Advisory Committee Act)
E:\FR\FM\16MYN1.SGM
16MYN1
27636
Federal Register / Vol. 72, No. 94 / Wednesday, May 16, 2007 / Notices
that a meeting of the Clinical Science
Research and Development Service
Cooperative Studies Scientific Merit
Review Board will be held on June 13,
2007, in the Capitol Room 5th Floor at
the International Square Center, 1875 I
Street NW., Washington, DC. The
meeting is scheduled to begin at 8:30
a.m. and end at 4 p.m.
The Board advises the Chief Research
and Development Officer through the
Director of the Clinical Science
Research and Development Service on
the relevance and feasibility of proposed
studies, the adequacy of the protocols
and the scientific validity and propriety
of technical details, including
protection of human subjects.
The session will be open to the public
from 8:30 a.m. to 9 a.m. for the
discussion of administrative matters and
the general status of the program. The
session will be closed from 9 a.m. to 4
p.m. for the Board’s review of research
and development applications.
During the closed portion of the
meeting, discussions and
recommendations will deal with
qualifications of personnel conducting
the studies, staff and consultant
critiques of research proposals and
similar documents, and the medical
records of patients who are study
subjects, the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy. As
provided by section 10(d) of Public Law
92–463, as amended, closing portions of
this meeting is in accordance with 5
U.S.C. 552b(c)(6) and (c)(9)(B).
Those who plan to attend should
contact Dr. Grant Huang, Deputy
Director, Cooperative Studies Program
(125), Department of Veterans Affairs,
810 Vermont Avenue, NW.,
Washington, DC 20420 at (202) 254–
0183.
Dated: May 9, 2007.
By direction of the Secretary.
E. Philip Riggin,
Committee Management Officer.
[FR Doc. 07–2395 Filed 5–15–07; 8:45 am]
BILLING CODE 8320–01–M
DEPARTMENT OF VETERANS
AFFAIRS
cprice-sewell on PROD1PC66 with NOTICES
Genomic Medicine Program Advisory
Committee; Notice of Meeting
The Department of Veterans Affairs
(VA) gives notice under Public Law 92–
463 (Federal Advisory Committee Act)
that the Genomic Medicine Program
Advisory Committee will meet on June
11, 2007 in the Virginia Room, 2nd
floor, at the Mayflower Renaissance
Hotel, 1127 Connecticut Avenue, NW.,
VerDate Aug<31>2005
15:27 May 15, 2007
Jkt 211001
Washington, DC. The meeting will
convene at 8 a.m. and adjourn at 5:30
p.m. The meeting is open to the public.
The purpose of the Committee is to
provide advice and make
recommendations to the Secretary of
Veterans Affairs on using genetic
information to optimize medical care of
veterans and to enhance development of
tests and treatments for diseases
particularly relevant to veterans.
At the June 11 meeting, the
Committee will receive an overview of
the VA health care system and
electronic medical record, and will be
asked to provide insight into optimal
ways for VA to incorporate genomic
information into its health care program
while applying appropriate ethical
oversight and protecting the privacy of
veterans.
Members of the public may make oral
statements, limited to 5 minutes each,
during the period reserved for public
comments. They may also submit, at the
time of the meeting, a 1–2 page
summary of each statement for
inclusion in the official meeting record.
Any member of the public seeking
additional information should contact
Dr. Timothy O’Leary at
timothy.oleary@va.gov.
Dated: May 9, 2007.
By direction of the Secretary.
E. Philip Riggin,
Committee Management Officer.
[FR Doc. 07–2397 Filed 5–15–07; 8:45 am]
BILLING CODE 8320–01–M
DEPARTMENT OF VETERANS
AFFAIRS
Advisory Committee on Women
Veterans; Notice of Meeting
The Department of Veterans Affairs
(VA) gives notice under Public Law 92–
463 (Federal Advisory Committee Act)
that the Advisory Committee on Women
Veterans will conduct a site visit on
June 4–8, 2007, to the VA Palo Alto
Health Care System (VAPAHCS), 3801
Miranda Avenue, Palo Alto, CA. Unless
otherwise indicated, all briefings and
updates will be held at the VA Palo Alto
Health Care System. Site visit briefings,
updates, and tours will be held from
8:30 a.m. until 4:30 p.m. each day and
will be open to the public.
The purpose of the Committee is to
advise the Secretary of Veterans Affairs,
regarding the needs of women veterans
with respect to health care,
rehabilitation, compensation, outreach,
and other programs and activities
administered by VA designed to meet
such needs. The Committee will make
PO 00000
Frm 00099
Fmt 4703
Sfmt 4703
recommendations to the Secretary
regarding such programs and activities.
On June 4, the agenda topics for this
meeting will include briefings and
updates from key leadership of the
VAPAHCS and Polytrauma Center, as
well as a tour of the polytrauma area,
Medical Surgical Intensive Care Unit
(MSICU), laboratory, hospice, and
pharmacy. On June 5, the Committee
will receive briefings and updates on
the VAPAHCS Women’s Health Center,
resident training, academic affairs/
research, quality assurance, and surgical
services.
On June 6, the Committee will receive
briefings from key leadership of the
Veterans Integrated Service Network 21
(Sierra Pacific Network), California State
Department of Veterans Affairs, Oakland
VA Regional Office, VA National
Cemetery Service, Redwood City Vet
Center, and VAPAHCS’s communitybased outpatient clinics (CBOSs).
On June 7, the Committee will visit
the Menlo Park Division of the
VAPAHCS, located at 795 Willow Road,
Menlo Park, CA. The Committee will
receive briefings and updates on the
Women’s Mental Health Program,
inpatient Post-Traumatic Stress Disorder
(PTSD), program, drug addiction
programs, crisis intervention, OIF Help
Center, chaplain services for women
veterans, and the Health Resources
Initiatives for Veterans Everywhere
(THRIVE). The Committee will tour the
resource center for women veterans, the
domiciliary, and the substance abuse
inpatient unit.
On June 8, the Committee will receive
briefings and updates on veteran service
organizations, nursing services, and
inpatient acute psychiatry building
plans for privacy issues. These
presentations will be followed by an
open forum and town hall meeting. The
five day site visit will conclude with an
exit briefing by VAPAHCS leadership.
Any member of the public wishing to
attend or seeking additional information
should contact Ms. Chanel BankstonCarter at the Department of Veterans
Affairs, Center for Women Veterans
(00W), 810 Vermont Avenue, NW.,
Washington, DC 20420. Ms. BankstonCarter may be contacted either by phone
at (202) 273–6193, fax at (202) 273–
7092, or e-mail at 00W@mail.va.gov.
Interested persons may attend, appear
before, or file statements with the
Committee. Written statements must be
filed before the meeting or within 10
days after the meeting.
Dated: May 9, 2007.
E:\FR\FM\16MYN1.SGM
16MYN1
Agencies
[Federal Register Volume 72, Number 94 (Wednesday, May 16, 2007)]
[Notices]
[Pages 27635-27636]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-2395]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Clinical Science Research and Development Service Cooperative
Studies Scientific Merit Review Board; Notice of Meeting
The Department of Veterans Affairs (VA) gives notice under Public
Law 92-463 (Federal Advisory Committee Act)
[[Page 27636]]
that a meeting of the Clinical Science Research and Development Service
Cooperative Studies Scientific Merit Review Board will be held on June
13, 2007, in the Capitol Room 5th Floor at the International Square
Center, 1875 I Street NW., Washington, DC. The meeting is scheduled to
begin at 8:30 a.m. and end at 4 p.m.
The Board advises the Chief Research and Development Officer
through the Director of the Clinical Science Research and Development
Service on the relevance and feasibility of proposed studies, the
adequacy of the protocols and the scientific validity and propriety of
technical details, including protection of human subjects.
The session will be open to the public from 8:30 a.m. to 9 a.m. for
the discussion of administrative matters and the general status of the
program. The session will be closed from 9 a.m. to 4 p.m. for the
Board's review of research and development applications.
During the closed portion of the meeting, discussions and
recommendations will deal with qualifications of personnel conducting
the studies, staff and consultant critiques of research proposals and
similar documents, and the medical records of patients who are study
subjects, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy. As provided by section 10(d)
of Public Law 92-463, as amended, closing portions of this meeting is
in accordance with 5 U.S.C. 552b(c)(6) and (c)(9)(B).
Those who plan to attend should contact Dr. Grant Huang, Deputy
Director, Cooperative Studies Program (125), Department of Veterans
Affairs, 810 Vermont Avenue, NW., Washington, DC 20420 at (202) 254-
0183.
Dated: May 9, 2007.
By direction of the Secretary.
E. Philip Riggin,
Committee Management Officer.
[FR Doc. 07-2395 Filed 5-15-07; 8:45 am]
BILLING CODE 8320-01-M